Navigation Links
Using Heart Stents Tends to Form More Clots

Cardiac patients who have implanted devices in their hearts face risks. The devices called stents.Stents are used to make arteries patent or open to allow an easy passage of// blood. It is inserted into cardiac arteries by surgeons.Stents may be medicated or non medicated that are coated with drugs are more liable to suffer from internal blood clotting. The risk is four to five times greater when compared to patients who use stents that are not medicated. This was gauged on the basis of a large study conducted recently.

Experts from the U.S FDA is scheduled to meet in the coming week to confer regarding the potential dangers of using medicated stents. These stents may trigger off formation of fatal blood clots.

The analysis presented by Cleveland Clinic which studied 6,675 patients is expected to snowball a massive debate regarding the safety factor of medicated stents Blood clots if formed, within arteries may lead to cardiac failure.

The American Journal of Medicine has published this study. The study mentions that that patients using stents coated with sirolimus, requires medication to prevent clotting to be taken for 2- 3 months, whereas stents that are coated with paclitaxel, needs anti clotting medicines to be taken for six months.

Researchers pointed out that the risks of developing clots, though small are definitely present with the use of drug coated. However they are useful in preventing repetitive invasive procedures on patients when compared with bare metal stents said experts Shares of companies that manufacture drug-coated stents have fallen in recent days amid concern the FDA panel will highlight the risks of the medical devices.

Boston Scientific and Johnson & Johnson, are the only two licensed companies in the fray having the major share of revenue generated from sale of stents. Medtronic Inc. and, Abbott Laboratories are also waiting to enter the U.S market by the year 2007-2008.

Related medicine news :

1. Preventing Strokes Using Less Invasive Techniques
2. Using Cholesterol Lowering Drugs Effectively
3. Using herbal remedies with chemotherapy may not be a good idea
4. Teenagers Using Hormones And Dietary Supplements To Good Physique
5. Using Stem Cells To Treat Incontinence In Women
6. Using Eyes As The Line Of Reference For Fetal Brain Imaging
7. Remote Robotic Surgery Using Miniature Robots
8. Driving While Using A Mobile Phone May Be Dangerous
9. Detecting Brain Abnormalities in Babies Using New Brain Scanners.
10. Mobilizing Stem Cells at the Injured Site Using Hyperbaric Oxygen Treatments.
11. Treatment of Sickle Cell Anemia Using Gene Therapy.
Post Your Comments:

(Date:12/1/2015)... N.C. (PRWEB) , ... December 01, 2015 , ... The ... to drive awareness and funds for Multiple System Atrophy (MSA) research, timed today to ... Atrophy takes many things from patients including their ability to work and be productive, ...
(Date:12/1/2015)... ... December 01, 2015 , ... The North American Meat Institute ... meat and poultry play in a healthy, balanced diet. , includes a ... can check their “meat IQ,” a section offering straight talk on controversies, information ...
(Date:12/1/2015)... , ... December 01, 2015 , ... World Patent ... Multi Jar, a container patent that allows for easier packing and organizing of items ... is worth $90 billion," says Scott Cooper, CEO and Creative Director of World Patent ...
(Date:12/1/2015)... (PRWEB) , ... December 01, 2015 , ... ... area in rural West Tennessee to receive Gigabit Internet through a partnership this ... of America’s largest cities, Henderson is an attractive destination for entrepreneurs who want ...
(Date:12/1/2015)... ... ... ClinicoEconomics and Outcomes Research has published the ... ”. , As corresponding author Dr Ankita Modi says “Pre-existing gastrointestinal events may ... a large US managed care database, women aged 55 years or older with ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... VANCOUVER , Dec. 1, 2015 /PRNewswire/ ... Pharmaceuticals, Inc. (NASDAQ: OGXI ) announced today that ... the pre-planned interim futility analysis of the intent-to-treat (ITT) ... issues were identified by the DMC. Both the DMC ... results are expected in the second half of 2016, ...
(Date:12/1/2015)... -- As enforcement of the Food and Drug ... approaches, InfiniTrak announced today new partnerships ... looming FDA regulations. --> ... with State Pharmacy Associations, an independent pharmacist association, ... exclusively provide the InfiniTrak track-and-trace software solution to ...
(Date:12/1/2015)... ) ... "Medium Molecular Weight Polyisobutylene Market for Gum ... - Global Industry Analysis, Size, Share, Growth, ... report to their offering. --> ... the "Medium Molecular Weight Polyisobutylene Market ...
Breaking Medicine Technology: